相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade (vol 26, pg 693, 2020)
Kobe C. Yuen et al.
NATURE MEDICINE (2021)
Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors
Kurt A. Schalper et al.
NATURE MEDICINE (2020)
β3 integrin immunohistochemistry as a method to predict sentinel lymph node status in patients with primary cutaneous melanoma
Enrica Quattrocchi et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2020)
Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial
Paolo A. Ascierto et al.
LANCET ONCOLOGY (2020)
Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model
Alexander M. M. Eggermont et al.
EUROPEAN JOURNAL OF CANCER (2020)
Model Combining Tumor Molecular and Clinicopathologic Risk Factors Predicts Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma
Domenico Bellomo et al.
JCO PRECISION ONCOLOGY (2020)
IL-6 and IL-8 Are Linked With Myeloid-Derived Suppressor Cell Accumulation and Correlate With Poor Clinical Outcomes in Melanoma Patients
Richard P. Tobin et al.
FRONTIERS IN ONCOLOGY (2019)
Management of local or regional non-nodal disease
Jennifer M. Racz et al.
JOURNAL OF SURGICAL ONCOLOGY (2019)
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
M. B. Faries et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The CXCL8-CXCR1/2 pathways in cancer
Qian Liu et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2016)
The interval between primary melanoma excision and sentinel node biopsy is not associated with survival in sentinel node positive patients - An EORTC Melanoma Group study
C. M. C. Oude Ophuis et al.
EJSO (2016)
Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab
Jeffrey Weber et al.
CANCER IMMUNOLOGY RESEARCH (2016)
In-transit Melanoma Metastases: Incidence, Prognosis, and the Role of Lymphadenectomy
Rebecca L. Read et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
One statistical test is sufficient for assessing new predictive markers
Andrew J. Vickers et al.
BMC MEDICAL RESEARCH METHODOLOGY (2011)
A sentinel node biopsy does not increase the incidence of in-transit metastasis in patients with primary cutaneous melanoma
D van Poll et al.
ANNALS OF SURGICAL ONCOLOGY (2005)
Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy
TM Pawlik et al.
ANNALS OF SURGICAL ONCOLOGY (2005)
Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanoma
JC Kang et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma
H Haghnegahdar et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2000)
分享论文
